AIM: To explore the associations of polymorphisms of lipopolysaccharide binding protein (LBP), cluster of differentiation 14 (CD14), toll-like receptor 4 (TLR-4), interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) with the colorectal carcinoma (CRC) risk in Han Chinese. METHODS: Polymorphisms of LBP (rs1739654, rs2232596, rs2232618), CD14 (rs77083413, rs4914), TLR-4 (rs5030719), IL-6 (rs13306435) and TNF-α (rs35131721) were genotyped in 479 cases of sporadic colorectal carcinoma and 486 healthy controls of Han Chinese in a case-control study. Single-nucleotide polymorphisms (SNPs) between cases and controls were analyzed by unconditional logistic regression. RESULTS: GA and GG genotypes of LBP rs2232596 were associated with a significantly increased risk of CRC [odds ratio (OR) = 1.51, 95% confidence interval (CI) 1.15-1.99, P = 0.003; OR = 2.49, 95% CI 1.16-5.38, P = 0.016, respectively]. A similar association was also observed for the CG genotype of CD14 rs4914 (OR= 1.69, 95% CI 1.20-2.36, P = 0.002). In addition, a combination of polymorphisms in LBP rs2232596 and CD14 rs4914 led to a 3.4-fold increased risk of CRC (OR = 3.44, 95% CI 1.94-6.10, P = 0.000). CONCLUSION: This study highlights the LBP rs2232596 and CD14 rs4914 polymorphisms as biomarkers for elevated CRC susceptibility in the Chinese Han population.
AIM: To explore the associations of polymorphisms of lipopolysaccharide binding protein (LBP), cluster of differentiation 14 (CD14), toll-like receptor 4 (TLR-4), interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) with the colorectal carcinoma (CRC) risk in Han Chinese. METHODS: Polymorphisms of LBP (rs1739654, rs2232596, rs2232618), CD14 (rs77083413, rs4914), TLR-4 (rs5030719), IL-6 (rs13306435) and TNF-α (rs35131721) were genotyped in 479 cases of sporadic colorectal carcinoma and 486 healthy controls of Han Chinese in a case-control study. Single-nucleotide polymorphisms (SNPs) between cases and controls were analyzed by unconditional logistic regression. RESULTS: GA and GG genotypes of LBPrs2232596 were associated with a significantly increased risk of CRC [odds ratio (OR) = 1.51, 95% confidence interval (CI) 1.15-1.99, P = 0.003; OR = 2.49, 95% CI 1.16-5.38, P = 0.016, respectively]. A similar association was also observed for the CG genotype of CD14rs4914 (OR= 1.69, 95% CI 1.20-2.36, P = 0.002). In addition, a combination of polymorphisms in LBPrs2232596 and CD14rs4914 led to a 3.4-fold increased risk of CRC (OR = 3.44, 95% CI 1.94-6.10, P = 0.000). CONCLUSION: This study highlights the LBPrs2232596 and CD14rs4914 polymorphisms as biomarkers for elevated CRC susceptibility in the Chinese Han population.
Authors: Doreen M Agnese; Jacqueline E Calvano; Sae J Hahm; Susette M Coyle; Siobhan A Corbett; Steve E Calvano; Stephen F Lowry Journal: J Infect Dis Date: 2002-10-29 Impact factor: 5.226
Authors: Jessica S Citronberg; Lynne R Wilkens; Loic Le Marchand; Unhee Lim; Kristine R Monroe; Meredith A J Hullar; Emily White; Polly A Newcomb; Johanna W Lampe Journal: Cancer Causes Control Date: 2017-11-30 Impact factor: 2.506
Authors: Cindy M Chang; Victoria M Chia; Marc J Gunter; Krista A Zanetti; Bríd M Ryan; Julie E Goodman; Curtis C Harris; Joel Weissfeld; Wen-Yi Huang; Stephen Chanock; Meredith Yeager; Richard B Hayes; Sonja I Berndt Journal: Carcinogenesis Date: 2013-06-26 Impact factor: 4.944
Authors: Alison L Van Dyke; Troy J Kemp; Amanda F Corbel; Bin Zhu; Yu-Tang Gao; Bing-Sheng Wang; Asif Rashid; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Ligia A Pinto; Jill Koshiol Journal: Ann Epidemiol Date: 2016-08-31 Impact factor: 3.797